Patients with gynecological cancer (breast, ovarian, vulvar, cervical, endometrial, and vaginal carcinoma) are included and questioned about urogynecological symptoms (urinary incontinence, prolapse symptoms, foreign body sensation).
Conditions
Interventions
Group 1: Patients with gynecological cancer who have received at least one previous treatment ( Surgery, anti-hormonal therapy, chemotherapy cycle) are included. Patients complete a one-time anonymous
Sponsors
Uniklinik Bonn, Klinik für Gynäkologie und gynäkologische Onkologie
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Sufficient knowledge of German
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The target criterion is the correlation between urogynecological symptoms (urinary incontinence, prolapse symptoms, foreign body sensation) in patients with gynecological malignancies. This is analyzed using a questionnaire that the patient fills out anonymously once. This can be done at any point during therapy, as long as at least one therapy has been completed so far (see above). The questionnaire can also be filled out during follow-up care. | — |
Secondary
| Measure | Time frame |
|---|---|
| Analysis of the care structures for gynecological cancer patients with regard to urogynecological symptoms to clarify when patients are informed about possible urogynecological side effects of cancer treatments. This is also analyzed using the questionnaire. | — |
Countries
Germany
Contacts
Public ContactCarolin Schröder
Uniklinik Bonn, Klinik für Gynäkologie und gynäkologische Onkologie
Outcome results
None listed